Detalhe da pesquisa
1.
Detection of Gene Rearrangements in Circulating Tumor Cells: Examples of ALK-, ROS1-, RET-Rearrangements in Non-Small-Cell Lung Cancer and ERG-Rearrangements in Prostate Cancer.
Adv Exp Med Biol
; 994: 169-179, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28560674
2.
Method for semi-automated microscopy of filtration-enriched circulating tumor cells.
BMC Cancer
; 16: 477, 2016 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27417942
3.
Circulating tumor cells in lung cancer.
Acta Cytol
; 56(6): 655-60, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23207444
4.
Genetic characterization of a unique neuroendocrine transdifferentiation prostate circulating tumor cell-derived eXplant model.
Nat Commun
; 11(1): 1884, 2020 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32313004
5.
An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate Cancer.
Eur Urol Oncol
; 3(4): 498-508, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31412010
6.
Circulating tumor cells (CTCs) for the noninvasive monitoring and personalization of non-small cell lung cancer (NSCLC) therapies.
J Thorac Dis
; 11(Suppl 1): S45-S56, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30775027
7.
Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK-Rearranged Non-Small-Cell Lung Cancer.
Clin Cancer Res
; 25(22): 6671-6682, 2019 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31439588
8.
Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven Cancers.
Cell Rep
; 29(1): 118-134.e8, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31577942
9.
Filter-Adapted Fluorescent In Situ Hybridization (FA-FISH) for Filtration-Enriched Circulating Tumor Cells.
Methods Mol Biol
; 1634: 133-141, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28819846
10.
Routine clinical use of circulating tumor cells for diagnosis of mutations and chromosomal rearrangements in non-small cell lung cancer-ready for prime-time?
Transl Lung Cancer Res
; 6(4): 444-453, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28904888
11.
Circulating Tumor Cells with Aberrant ALK Copy Number Predict Progression-Free Survival during Crizotinib Treatment in ALK-Rearranged Non-Small Cell Lung Cancer Patients.
Cancer Res
; 77(9): 2222-2230, 2017 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28461563
12.
The potential diagnostic power of circulating tumor cell analysis for non-small-cell lung cancer.
Expert Rev Mol Diagn
; 15(12): 1605-29, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26564313
13.
Clinical Utility of Circulating Tumor Cells in ALK-Positive Non-Small-Cell Lung Cancer.
Front Oncol
; 4: 281, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25414829
14.
Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer.
J Clin Oncol
; 31(18): 2273-81, 2013 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23669222